Built to fill gaps.
BiotechComm partners with medical device, diagnostic, life sciences, and biotech companies at every stage, from early founders to later-stage and public companies, to identify what's missing from the strategy, the operations, or the team, and bring in exactly the expertise it takes to close the gap.
Backed by an extensive network of industry experts across therapeutic and device areas.
What BiotechComm does.
Seven capabilities, drawn on individually or together, depending on what the plan calls for.
Strategy & Planning
Real goals and a written strategic plan specific enough to act on right away.
Operations & Accountability
Operating process design, progress tracking, and the accountability systems to keep a plan running.
Fundraising
Identifying the right targets and building the tools it takes to support the capital raise.
Commercial Strategy & Market Assessment
Commercial plans built on a clear-eyed read of the market, the competition, and how the product actually gets adopted.
Physician & KOL Engagement
Building and developing the physician and key opinion leader relationships that carry a product into practice.
Communications, Advocacy & Crisis Management
Crisis communications, media relations, investor relations, patient advocacy, and executive narrative coaching, built and ready before they're needed.
Brand Strategy & Rebranding
Full rebrands and repositioning for companies redefining how the market sees them.
Built for where you are.
We meet medical device, diagnostic, life sciences, and biotech companies at whichever stage they're in, with a bespoke plan built around where each one actually stands, never a template.
Earlier-Stage Companies
We help build out the company itself, the strategic plan and the operations infrastructure to run it: real goals, an operating process to reach them, a cadence for tracking progress, and the accountability to keep it running six months in, not just at kickoff.
- Strategy & goal-setting
- Operating process design
- Progress tracking & reporting
- Accountability systems
Later-Stage Companies
For companies further along, we refine strategy, jump in on specific projects, and support rebranding or repositioning, backed by an extensive network of specialists across therapeutic and device areas, brought in exactly where a project calls for them.
- Strategy refinement & market assessment
- Project-based execution
- Rebranding & repositioning
- Financial modeling & capital raises
- Commercial & communications specialists
The same sequence, every time.
Assess
An honest read on where things actually stand: the technology, the evidence, the runway, the readiness.
Plan
Strategy and goals, put in writing and specific enough to act on right away.
Execute
Process, tracking, and accountability put in place, and the right specialists brought in at the right moment, all coordinated against one plan.
Fit to where you are.
Fractional
Ongoing, part-time leadership across strategy and planning, for teams that need senior judgment before they need a full-time hire.
Project-Based
A defined scope with a clear endpoint (a financial model, a commercial plan, a rebrand) or jumping into an initiative already underway, delivered on a set timeline.
Capital Sprint
A focused push to get a raise fundraising-ready: model, materials, data room, and outreach strategy, built to move fast.
Built on operating experience, not advisory theory.
Founded in 2009 by E. Blair Clark-Schoeb, BiotechComm brings approximately 30 years of industry experience to every engagement, working with companies from early-stage medical device companies to major pharmaceutical organizations.
That experience is grounded in direct operating work inside medical device, diagnostic, life sciences, and biotech companies: running commercial strategy, owning reimbursement and adoption conversations, building physician and KOL relationships, and sitting in the room for fundraising.
It's backed by an extensive network of industry experts across therapeutic and device areas, brought in the moment a plan calls for a specific capability, from financial modeling to commercial launch and brand strategy. We've led full rebrands and repositioning efforts for companies redefining how the market sees them.
The work spans every stage: early founders building a first plan, later-stage companies refining strategy and positioning, and public companies navigating what's next.